Nonalcoholic fatty liver disease stratification by liver lipidomics.


Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
2021
Historique:
received: 11 05 2021
revised: 20 07 2021
accepted: 30 07 2021
pubmed: 14 8 2021
medline: 25 3 2022
entrez: 13 8 2021
Statut: ppublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is a common metabolic dysfunction leading to hepatic steatosis. However, NAFLD's global impact on the liver lipidome is poorly understood. Using high-resolution shotgun mass spectrometry, we quantified the molar abundance of 316 species from 22 major lipid classes in liver biopsies of 365 patients, including nonsteatotic patients with normal or excessive weight, patients diagnosed with NAFL (nonalcoholic fatty liver) or NASH (nonalcoholic steatohepatitis), and patients bearing common mutations of NAFLD-related protein factors. We confirmed the progressive accumulation of di- and triacylglycerols and cholesteryl esters in the liver of NAFL and NASH patients, while the bulk composition of glycerophospho- and sphingolipids remained unchanged. Further stratification by biclustering analysis identified sphingomyelin species comprising n24:2 fatty acid moieties as membrane lipid markers of NAFLD. Normalized relative abundance of sphingomyelins SM 43:3;2 and SM 43:1;2 containing n24:2 and n24:0 fatty acid moieties, respectively, showed opposite trends during NAFLD progression and distinguished NAFL and NASH lipidomes from the lipidome of nonsteatotic livers. Together with several glycerophospholipids containing a C22:6 fatty acid moiety, these lipids serve as markers of early and advanced stages of NAFL.

Identifiants

pubmed: 34384788
pii: S0022-2275(21)00086-9
doi: 10.1016/j.jlr.2021.100104
pmc: PMC8488246
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

100104

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Références

Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
J Hepatol. 2020 Jun;72(6):1196-1209
pubmed: 32145256
J Pediatr Gastroenterol Nutr. 2018 Jul;67(1):69-74
pubmed: 29601441
Cold Spring Harb Perspect Biol. 2011 Sep 01;3(9):a004614
pubmed: 21610115
Genome Biol. 2011;12(1):R8
pubmed: 21247462
Nat Commun. 2018 Oct 8;9(1):4150
pubmed: 30297808
Sci Rep. 2017 Apr 24;7:46658
pubmed: 28436449
Hum Mol Genet. 2018 Jun 15;27(12):2214-2223
pubmed: 29648650
PLoS One. 2009 Jul 15;4(7):e6261
pubmed: 19603071
J Lipid Res. 2018 Oct;59(10):2001-2017
pubmed: 30115755
Diabetes Metab Syndr Obes. 2018 Sep 25;11:533-542
pubmed: 30288073
J Lipid Res. 2017 Dec;58(12):2275-2288
pubmed: 28986437
Mol Metab. 2021 Aug;50:101111
pubmed: 33160101
JAMA Netw Open. 2019 Oct 2;2(10):e1912565
pubmed: 31584681
Eur J Lipid Sci Technol. 2014 Dec;116(12):1618-1620
pubmed: 26052249
J Lipid Res. 2011 Dec;52(12):2314-2322
pubmed: 21960706
Bioinformatics. 2011 Feb 15;27(4):572-7
pubmed: 21169379
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82
pubmed: 12629214
Biochim Biophys Acta. 2014 May;1841(5):647-56
pubmed: 24184514
J Lipid Res. 2017 Jan;58(1):247-255
pubmed: 27836992
Hepatology. 2017 Jun;65(6):1875-1890
pubmed: 28073161
N Engl J Med. 2011 Nov 10;365(19):1812-23
pubmed: 22070478
Gastroenterology. 2016 May;150(5):1219-1230.e6
pubmed: 26850495
Gut. 2021 May;70(5):940-950
pubmed: 32591434
Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Hepatology. 2019 Oct;70(4):1457-1469
pubmed: 30924946
J Clin Invest. 2005 May;115(5):1139-42
pubmed: 15864343
Eur J Lipid Sci Technol. 2015 Oct;117(10):1540-1549
pubmed: 26494980
Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):445-51
pubmed: 19673631
Anal Chem. 2017 Jul 5;89(13):7046-7052
pubmed: 28570056
Anal Chem. 2017 Dec 5;89(23):12857-12865
pubmed: 29111682
J Hepatol. 2016 Dec;65(6):1263-1265
pubmed: 27520876
Biochem Biophys Res Commun. 2018 Oct 7;504(3):608-616
pubmed: 29778532
Nat Methods. 2017 Dec;14(12):1171-1174
pubmed: 29058722
Gut. 2019 Jun;68(6):1099-1107
pubmed: 30068662
Methods Cell Biol. 2013;116:107-27
pubmed: 24099290
J Gastroenterol. 2013 Apr;48(4):434-41
pubmed: 23397118
Sci Rep. 2018 Sep 21;8(1):14200
pubmed: 30242179
iScience. 2022 Aug 15;25(9):104949
pubmed: 36065182
Trends Immunol. 2018 Sep;39(9):712-723
pubmed: 29843959
Acc Chem Res. 2016 Sep 20;49(9):1596-604
pubmed: 27575732
Nat Commun. 2016 Sep 15;7:12757
pubmed: 27630043
Gut. 2012 Jan;61(1):150-9
pubmed: 22110053
Curr Opin Lipidol. 2008 Jun;19(3):242-7
pubmed: 18460914
Int J Mol Sci. 2019 Dec 19;21(1):
pubmed: 31861664
Adv Exp Med Biol. 2011;721:87-97
pubmed: 21910084
Biol Rev Camb Philos Soc. 2016 May;91(2):452-68
pubmed: 25740151
Trends Endocrinol Metab. 2017 Jul;28(7):506-518
pubmed: 28462811
Nat Genet. 2015 Dec;47(12):1443-8
pubmed: 26482880
Hippokratia. 2009 Jan;13(1):9-19
pubmed: 19240815
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Jul;1865(7):158683
pubmed: 32169653
J Hepatol. 2017 Jan;66(1):195-211
pubmed: 27575312
Hepatology. 2017 Jun;65(6):1840-1850
pubmed: 28109005
Sci Rep. 2016 Jun 14;6:27710
pubmed: 27295977
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9521-9526
pubmed: 31019090
Annu Rev Pathol. 2016 May 23;11:451-96
pubmed: 26980160
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Dec;1863(12):1441-1448
pubmed: 30251650
Anal Chem. 2018 Aug 21;90(16):9868-9878
pubmed: 30004672
Anal Chem. 2020 Oct 20;92(20):14054-14062
pubmed: 33003696
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 May 15;1053:72-80
pubmed: 28415015
Science. 2011 Jun 24;332(6037):1519-23
pubmed: 21700865
Methods Mol Biol. 2017;1619:203-212
pubmed: 28674888
Nucleic Acids Res. 2009 Aug;37(15):e101
pubmed: 19509312
Nat Chem Biol. 2018 Nov;14(11):1021-1031
pubmed: 30327559
Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Mar;67(3 Pt 1):031902
pubmed: 12689096
Endocr Rev. 2020 Jan 1;41(1):
pubmed: 31629366
Int J Obes (Lond). 2021 Aug;45(8):1844-1854
pubmed: 33994541
Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158579
pubmed: 31794862
Anal Bioanal Chem. 2004 Feb;378(4):875-82
pubmed: 14598004
Compr Physiol. 2017 Dec 12;8(1):1-8
pubmed: 29357123
J Mass Spectrom. 2012 Jan;47(1):96-104
pubmed: 22282095
Front Cell Dev Biol. 2019 Oct 25;7:248
pubmed: 31709254
World J Gastroenterol. 2019 Jun 28;25(24):3009-3020
pubmed: 31293337
J Lipid Res. 2015 Mar;56(3):722-736
pubmed: 25598080
Nat Med. 2018 Jul;24(7):908-922
pubmed: 29967350
J Lipid Res. 2006 Jan;47(1):181-92
pubmed: 16222032
Trials. 2018 Dec 29;19(1):709
pubmed: 30594232
Am J Gastroenterol. 2018 Oct;113(10):1475-1483
pubmed: 29535416
JCI Insight. 2019 Aug 22;4(16):
pubmed: 31434800
Hepatology. 2003 Apr;37(4):909-16
pubmed: 12668986
PLoS One. 2020 Jun 16;15(6):e0228521
pubmed: 32544198

Auteurs

Olga Vvedenskaya (O)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Tim Daniel Rose (TD)

LipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Munich, Germany.

Oskar Knittelfelder (O)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Alessandra Palladini (A)

Paul Langerhans Institute Dresden of the Helmholtz Zentrum Munich at the University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.

Judith Andrea Heidrun Wodke (JAH)

Theoretical Biophysics, Humboldt-Universität zu Berlin, Berlin, Germany.

Kai Schuhmann (K)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Jacobo Miranda Ackerman (JM)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Yuting Wang (Y)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Canan Has (C)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany.

Mario Brosch (M)

Department of Medicine I, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, Germany.

Veera Raghavan Thangapandi (VR)

Department of Medicine I, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, Germany.

Stephan Buch (S)

Department of Medicine I, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Germany; Center for Regenerative Therapies Dresden (CRTD), Technische Universität (TU) Dresden, Dresden, Germany.

Thomas Züllig (T)

Core Facility Mass Spectrometry, Medical University of Graz, Graz, Austria.

Jürgen Hartler (J)

Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria; Field of Excellence BioHealth, University of Graz, Graz, Austria.

Harald C Köfeler (HC)

Core Facility Mass Spectrometry, Medical University of Graz, Graz, Austria.

Christoph Röcken (C)

Department of Pathology, University Hospital Schleswig Holstein, Kiel, Schleswig-Holstein, Germany.

Ünal Coskun (Ü)

Paul Langerhans Institute Dresden of the Helmholtz Zentrum Munich at the University Hospital Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany; Department of Membrane Biochemistry and Lipid Research, University Hospital Carl Gustav Carus of Technische Universität Dresden, Dresden, Germany.

Edda Klipp (E)

Theoretical Biophysics, Humboldt-Universität zu Berlin, Berlin, Germany.

Witigo von Schoenfels (W)

Department of Visceral and Thoracic Surgery, University Hospital Schleswig-Holstein, Kiel Campus, Christian-Albrechts-University Kiel, Kiel, Germany; Christian Albrechts University in Kiel Center of Clinical Anatomy Kiel, Schleswig-Holstein, Germany.

Justus Gross (J)

Department of General, Visceral, Vascular and Transplant Surgery, Rostock University Medical Center, Rostock, Germany.

Clemens Schafmayer (C)

Department of General, Visceral, Vascular and Transplant Surgery, Rostock University Medical Center, Rostock, Germany.

Jochen Hampe (J)

Department of Medicine I, University Hospital Dresden, Technische Universität (TU) Dresden, Dresden, Germany.

Josch Konstantin Pauling (JK)

LipiTUM, Chair of Experimental Bioinformatics, TUM School of Life Sciences, Technical University of Munich, Munich, Germany. Electronic address: josch.pauling@wzw.tum.de.

Andrej Shevchenko (A)

Max Planck Institute of Molecular Cell Biology and Genetics, Dresden, Germany. Electronic address: shevchenko@mpi-cbg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH